Biome

Information, not medical advice. Not a substitute for clinical care. All modeled outputs are conditional estimates, not predictions.

Peptides

Ipamorelin / CJC-1295

Hype watchContestedUnregulated

Growth hormone secretagogues with pharmacokinetic data but limited long-term outcome evidence.

Proposed mechanism

Stimulate pulsatile growth hormone release via ghrelin receptor agonism (ipamorelin) or GHRH analog activity (CJC-1295). Affect IGF-1, body composition, and recovery.

Strongest evidence

Human pharmacokinetic and GH/IGF-1 elevation confirmed in small studies. Body composition improvements in limited trials. Long-term safety and outcome data lacking.

What's contested or hyped

Anti-aging and performance claims exceed current evidence. Optimal dosing, cycling, and monitoring protocols are not established.

Biome describes modalities; it does not recommend protocols, products, or providers. Consult qualified clinicians for medical decisions.